Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Simulations Plus, Inc.

Market Cap 333M 289M 267M 250M 467M 31.9B 476M 3.18B 1.23B 15.38B 1.25B 1.22B 53.47B P/E Ratio 2026 *
39.5x
P/E Ratio 2027 * 36.4x
Enterprise Value 333M 289M 267M 250M 467M 31.9B 476M 3.18B 1.23B 15.38B 1.25B 1.22B 53.47B EV / Sales 2026 *
4.08x
EV / Sales 2027 * 3.85x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day+3.45%
1 week-0.96%
Current month-3.62%
1 month+12.25%
3 months+32.24%
6 months-15.48%
Current year-9.54%
1 week 15.64
Extreme 15.64
16.67
1 month 13.21
Extreme 13.21
17.76
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 6.74
Extreme 6.74
90.92
Manager TitleAgeSince
Chief Executive Officer 67 2018-06-25
Director of Finance/CFO 63 2020-11-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 1996-07-16
Director/Board Member 58 2014-12-02
Chairman 76 2024-12-16
Date Insider Type Main position Quantity % Market Cap.
06-02Sell

Executive/Senior Manager

-1,000 0.0050%
05-31Sell

Founder

-15,000 0.0745%
05-10Fiscal year

Executive/Senior Manager

3,000 0.0149%
Change 5-day change 1-year change 3-year change Capi.($)
+3.45%-0.96%-37.63%-63.31% 333M
-1.35%-9.55%-44.01%-13.89% 26.24B
+0.74%-0.99%-41.24%+150.96% 11.9B
+0.76%+4.10%-4.63%+57.38% 6.1B
+4.21%+6.46% - - 2.65B
-0.94%-13.26%+24.45%-47.65% 1.72B
-1.75%-12.04% - - 1.66B
+2.32%-0.30%-32.87% - 1.26B
-3.29%-3.55%-35.35%-60.11% 807M
+4.26%+1.19%-30.14%+220.06% 767M
Average +0.84%-3.36%-25.18%+34.78% 5.34B
Weighted average by Cap. -0.20%-4.52%-35.36%+37.57%

Financials

2026 *2027 *
Net sales 81.75M 70.95M 65.4M 61.28M 114M 7.83B 117M 780M 302M 3.77B 307M 300M 13.12B 86.53M 75.09M 69.22M 64.86M 121M 8.29B 124M 826M 320M 3.99B 325M 318M 13.89B
Net income 9.02M 7.83M 7.22M 6.76M 12.64M 864M 12.9M 86.09M 33.33M 416M 33.87M 33.14M 1.45B 9.71M 8.43M 7.77M 7.28M 13.6M 930M 13.88M 92.65M 35.87M 448M 36.45M 35.66M 1.56B
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
26-06-11 16.49 $ +3.45% 171,492
26-06-10 15.94 $ -0.44% 172,893
26-06-09 16.01 $ +0.63% 182,321
26-06-08 15.91 $ +0.19% 184,027
26-06-05 15.88 $ -4.62% 204,247
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
16.49USD
Average target price
23.50USD
Spread / Average Target
+42.51%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!